0001209191-20-054839.txt : 20201014 0001209191-20-054839.hdr.sgml : 20201014 20201014192704 ACCESSION NUMBER: 0001209191-20-054839 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201014 FILED AS OF DATE: 20201014 DATE AS OF CHANGE: 20201014 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Giraudo Bryan CENTRAL INDEX KEY: 0001740847 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38796 FILM NUMBER: 201240042 MAIL ADDRESS: STREET 1: 7707 GATEWAY BOULEVARD, SUITE 140 CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Gossamer Bio, Inc. CENTRAL INDEX KEY: 0001728117 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 475461709 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 922-0718 MAIL ADDRESS: STREET 1: 3013 SCIENCE PARK CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-10-14 0 0001728117 Gossamer Bio, Inc. GOSS 0001740847 Giraudo Bryan 3013 SCIENCE PARK ROAD SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Common Stock 2020-10-14 4 P 0 3000 10.012 A 7121 I By family trust Common Stock 70379 D This transaction was executed in multiple trades at prices ranging from $9.41 to $10.31 per share. The price reported above reflects the weighted average sale price for the entire number of shares purchased. Information on the exact number of shares purchased at each sale price can be obtained from the Issuer upon request. Includes 46,500 restricted stock units granted in February 2020, which shares will vest in three equal annual installments in accordance with the terms of the award and subject to the Reporting Person's continuous service to the Issuer on each vesting date. /s/ Jeff Boerneke, Attorney-in-Fact 2020-10-14